THURSDAY, Oct. 15, 2020 — The first drug for Zaire ebolavirus (Ebola virus) infection has been approved for adults and children, the U.S. Food and Drug Administration announced Wednesday. Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) is a mixture of three monoclonal antibodies that simultaneously block entry of the virus. The approval also applies to newborns of mothers who have tested positive […]
» Read more
New research suggests that it may be possible to simplify the diagnosis of deep vein thrombosis (DVT) without compromising accuracy. Contrary to the standard practice of administering several tests to diagnose DVT, using only a D-dimer blood test may help health care providers identify patients who require additional screening, according to a new study in Blood Advances. DVT occurs when […]
» Read more
By exposing larval zebrafish to a well-known optical illusion, researchers at the Max Planck Institute of Neurobiology and National Institute of Genetics in Japan have found a clever way to isolate key clusters of neurons critical to processing the direction of motion in the zebrafish’s environment. Details were published in the journal Neuron in September 2020. Understanding how animal brains […]
» Read more
Six feet: You've heard that measurement everywhere by now—from officials at the Centers for Disease Control and Prevention (CDC); on coronavirus-themed TV commercials; in literally every COVID-19 article circulating the internet. For the most part, we all know that when we have to go out into the world, we should maintain a 6-foot distance between ourselves and those around us. […]
» Read more
When health secretary Matt Hancock launched NHSX in April 2019 it was with much optimism and fanfare. However, over the last few months, the digital health unit has come under scrutiny due to the pressures brought on by the pandemic, highlighting concerns about its procurement strategy and fitness for purpose. Yesterday, NHSX chief executive Matthew Gould delivered a Q&A keynote at the […]
» Read more
We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights. Most patients of COVID-19 are told they will recover from mild coronavirus infections within two weeks and from more serious infection within three. However, new reports are stating that thousands could be living with long COVID symptoms. […]
» Read more
All my life I’ve been involved in music and molecular biology. At the crossroads between science and art, I see great scope for insight. My latest research, published in the journal BMC Bioinformatics, reveals how music can be used to reveal functional properties of the coronavirus genome. This project followed earlier work I had done generating audio from human DNA […]
» Read more
Even before we were spending so much time at home and were encouraged to avoid unnecessary public outings this year, courier services were having a tech-fueled renaissance. And since working — and doing pretty much everything else — from home has become the norm, same-day (and even same-hour) delivery hasn't just expanded, it's exploded. Uber Eats and Grubhub have been […]
» Read more
During the pandemic, the amount of screen time for many people working and learning from home as well as binge-watching TV has sharply increased. New research finds that wearing blue-light glasses just before sleeping can lead to a better night’s sleep and contribute to a better day’s work to follow. “We found that wearing blue-light-filtering glasses is an effective intervention […]
» Read more
Bianka Bella is having some fun with Candace Parker! Vanessa Bryant's 3½-year-old daughter can be seen grinning ear to ear as she plays with the Los Angeles Sparks star, 34, in a sweet photo posted to Parker's Instagram on Wednesday. In the shot, Bianka flashes a huge smile as Parker sits inside a Frozen playhouse. "This little cutie can lock me […]
» Read more